Skip to main content
. Author manuscript; available in PMC: 2021 Sep 23.
Published in final edited form as: Cancer. 2020 Sep 23;127(1):82–92. doi: 10.1002/cncr.33208

Table 2.

Post auto-HCT maintenance therapy

AA w t(11;14) AA w/o t(11;14) Whites w t(11;14) Whites w/o t(11;14)
Number of patients 117 968 266 2,187
Bortezomib/Lenalidomide ± other 14 (12) 97 (10) 42 (16) 304 (14)
Bortezomib ± other (no Lenalidomide) 6 (5) 71 (7) 17 (6) 132 (6)
Lenalidomide ± other (no Bortezomib) 46 (39) 461 (48) 106 (40) 861 (39)
Other 15 (13) 103 (11) 28 (11) 304 (14)
No maintenance 35 (30) 236 (24) 73 (27) 580 (27)
Missing 1 (<1) 0 0 6 (<1)

w: with, w/o: without. AA- African American